相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Repurposing of a drug scaffold: Identification of novel sila analogues of rimonabant as potent antitubercular agents
Remya Ramesh et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Design, synthesis and antimycobacterial evaluation of some new azaheterocycles with the 4,7-phenanthroline skeleton. Part VI
Cristina M. Al Matarneh et al.
JOURNAL OF THE SERBIAN CHEMICAL SOCIETY (2016)
New indolizines with phenanthroline skeleton: Synthesis, structure, antimycobacterial and anticancer evaluation
Ramona Danac et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Comprehensive physicochemical, pharmacokinetic and activity profiling of anti-TB agents
Suresh B. Lakshminarayana et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Antimycobacterial activity of nitrogen heterocycles derivatives: Bipyridine derivatives. Part III [13,14]
Ramona Danac et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Design, Synthesis and Antimycobacterial Activity of Some New Azaheterocycles: Phenanthroline with p-halo-benzoyl Skeleton. Part V
Ramona Danac et al.
Letters in Drug Design & Discovery (2014)
A Dual Read-Out Assay to Evaluate the Potency of Compounds Active against Mycobacterium tuberculosis
Juliane Ollinger et al.
PLOS ONE (2013)
Dicoumarol complexes of Cu(II) based on 1,10-phenanthroline: Synthesis, X-ray diffraction studies, thermal behavior and biological evaluation
Hitesh R. Dholariya et al.
SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY (2013)
Generation and exploration of new classes of antitubercular agents: The optimization of oxazolines, oxazoles, thiazolines, thiazoles to imidazo[1,2-a]pyridines and isomeric 5,6-fused scaffolds
Garrett C. Moraski et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2012)
Construction and functionalization of fused pyridine ring leading to novel compounds as potential antitubercular agents
Balakrishna Dulla et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Targeting the mycobacterial envelope for tuberculosis drug development
Lorenza Favrot et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2012)
A new in vivo model to test anti-tuberculosis drugs using fluorescence imaging
Andrea Zelmer et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Scaling up interventions to achieve global tuberculosis control: progress and new developments
Mario Raviglione et al.
LANCET (2012)
Synthesis and antituberculosis activity of some new pyridazine derivatives. Part II
Donna Mantu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2010)
The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery
Dennis A. Smith et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Sensitive Detection of Gene Expression in Mycobacteria under Replicating and Non-Replicating Conditions Using Optimized Far-Red Reporters
Paul Carroll et al.
PLOS ONE (2010)
Optimisation of Bioluminescent Reporters for Use with Mycobacteria
Nuria Andreu et al.
PLOS ONE (2010)
The Population Dynamics and Control of Tuberculosis
Christopher Dye et al.
SCIENCE (2010)
New pyridazine derivatives: Synthesis, chemistry and biological activity
Roxana M. Butnariu et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2009)
In vitro evaluation of reversible and irreversible cytochrome P450 inhibition:: Current status on methodologies and their utility for predicting drug-drug interactions
Stephen Fowler et al.
AAPS JOURNAL (2008)
Applications of high throughput microsomal stability assay in drug discovery
Li Di et al.
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING (2008)
Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis
Sang Hyun Cho et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
The role of transporters in drug interactions
CJ Endres et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2006)
High-throughput screening of inhibitory potential of nine cytochrome P450 enzymes in vitro using liquid chromatography/tandem mass spectrometry
MJ Kim et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2005)
Validated assays for human cytochrome P450 activities
RL Walsky et al.
DRUG METABOLISM AND DISPOSITION (2004)
Development and validation of a 96-well equilibrium dialysis apparatus for measuring plasma protein binding
MJ Banker et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2003)
Cytotoxicity tests for high-throughput drug discovery
K Slater
CURRENT OPINION IN BIOTECHNOLOGY (2001)
Susceptibility testing: accurate and reproducible minimum inhibitory concentration (MIC) and non-inhibitory concentration (NIC) values
RJW Lambert et al.
JOURNAL OF APPLIED MICROBIOLOGY (2000)
分享论文
